{"i": ["bilastine"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["bilastine"], "o": []}
{"i": ["placebo - controlled"], "o": []}
{"i": ["bilastine", "placebo"], "o": []}
{"i": [], "o": ["change in critical temperature thresholds ( CTT )."]}
{"i": ["bilastine"], "o": ["changes in pruritus , levels of histamine IL - 6 , IL - 8 and TNF - \u03b1 collected by skin microdialysis and safety and tolerability"]}
{"i": ["Bilastine"], "o": ["CTT"]}
{"i": [], "o": ["effectiveness ."]}
{"i": [], "o": ["symptom free ."]}
{"i": [], "o": []}
{"i": ["bilastine"], "o": ["Microdialysis levels of histamine , IL - 6 and IL - 8"]}
{"i": ["Bilastine treat - ment"], "o": ["sedation", "tolerated"]}
{"i": ["Bilastine"], "o": []}
{"i": ["bilastine"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["bilastine"], "o": []}
{"i": ["placebo - controlled"], "o": []}
{"i": ["bilastine", "placebo"], "o": []}
{"i": [], "o": ["change in critical temperature thresholds ( CTT )."]}
{"i": ["bilastine"], "o": ["changes in pruritus , levels of histamine IL - 6 , IL - 8 and TNF - \u03b1 collected by skin microdialysis and safety and tolerability"]}
{"i": ["Bilastine"], "o": ["CTT"]}
{"i": [], "o": ["effectiveness ."]}
{"i": [], "o": ["symptom free ."]}
{"i": [], "o": []}
{"i": ["bilastine"], "o": ["Microdialysis levels of histamine , IL - 6 and IL - 8"]}
{"i": ["Bilastine treat - ment"], "o": ["sedation", "tolerated"]}
{"i": ["Bilastine"], "o": []}
{"i": ["bilastine"], "o": []}
{"i": [], "o": []}
{"i": ["H1 - antihistamine , bilastine"], "o": []}
{"i": ["Bilastine"], "o": []}
{"i": ["bilastine"], "o": []}
{"i": ["bilastine"], "o": []}
{"i": ["bilastine", "lorazepam"], "o": []}
{"i": ["Bilastine"], "o": []}
{"i": ["bilastine"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["CCU"], "o": []}
{"i": ["leukotriene antagonists , ciclosporin , antibiotics and anti - IgE therapy"], "o": []}
{"i": ["antihistamines"], "o": []}
{"i": ["antihistamines"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["bilastine"], "o": []}
{"i": [], "o": []}
{"i": ["bilastine"], "o": ["wheal responses", "CTT"]}
{"i": ["bilastine"], "o": ["safety and tolerability"]}
{"i": ["placebo - controlled", "bilastine", "placebo"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["wheal and itching"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["antihistamines , antidepressants , antipsychotics or corticosteroids , aluminium - and magnesium - containing antacids , ketoconazole and erythromycin", "topically applied antihistamines , corticosteroids or mast cell stabilizers"], "o": []}
{"i": ["citrus fruits"], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["critical temperature threshold ( CTT )"]}
{"i": [], "o": []}
{"i": [], "o": ["levels of histamine , IL - 6 , IL - 8 and TNF - \u03b1"]}
{"i": ["placebo , bilastine"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["cold urticaria symptom development ."]}
{"i": [], "o": ["Cold urticaria provocation and measurements of response"]}
{"i": ["bilastine ."], "o": []}
{"i": ["bilastine or placebo"], "o": []}
{"i": ["bilastine", "placebo"], "o": []}
{"i": [], "o": []}
{"i": ["fruit juice drinks"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["a wheal , either confluent or nonconfluent", "itching"]}
{"i": [], "o": ["severities of itching and burning of the cold - induced lesions"]}
{"i": [], "o": ["pruritus and burning"]}
{"i": [], "o": ["release of histamine", "generation of cytokines IL - 6 , IL - 8 and TNF - \u03b1 ."]}
{"i": ["topical local anaesthesia ( EMLA cream"], "o": []}
{"i": [], "o": []}
{"i": ["Ringer ' s solution"], "o": []}
{"i": [], "o": ["mediator levels"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["Histamine"]}
{"i": [], "o": ["Cytokines"]}
{"i": [], "o": []}
{"i": ["H1 - antihistamine"], "o": []}
{"i": [], "o": ["critical temperature thresholds and pruritus"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["histamine and cytokines"]}
{"i": ["placebo"], "o": ["median CTT"]}
{"i": [], "o": ["symptom free", "whealing response"]}
{"i": ["bilastine", "placebo"], "o": ["median CTT value"]}
{"i": [], "o": []}
{"i": ["placebo"], "o": ["symptom free"]}
{"i": ["Placebo Bilastine", "bilastine", "Bilastine"], "o": ["critical temperature thresholds ( CTT )"]}
{"i": ["bilastine"], "o": ["median CTT values"]}
{"i": ["placebo"], "o": []}
{"i": [], "o": []}
{"i": ["bilastine"], "o": ["median CTT"]}
{"i": ["placebo"], "o": ["symptom free"]}
{"i": [], "o": ["number of patients becoming symptom free ."]}
{"i": ["bilastine"], "o": []}
{"i": ["placebo"], "o": ["pruritus score", "itch"]}
{"i": [], "o": []}
{"i": ["bilastine", "placebo"], "o": ["itch", "median pruritus score"]}
{"i": ["bilastine"], "o": ["median pruritus scores"]}
{"i": ["placebo"], "o": []}
{"i": ["bilastine", "placebo"], "o": ["pruritus"]}
{"i": [], "o": []}
{"i": ["bilastine"], "o": ["pruritus ."]}
{"i": ["placebo"], "o": ["burning sensation"]}
{"i": ["bilastine"], "o": ["burning"]}
{"i": ["bilastine"], "o": ["burning"]}
{"i": ["bilastine"], "o": ["burning"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["concentration of histamine"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["bilastine"], "o": ["histamine in provoked skin"]}
{"i": [], "o": ["mean histamine level"]}
{"i": [], "o": []}
{"i": ["bilastine"], "o": ["mean histamine levels in provoked skin"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["IL - 8"]}
{"i": [], "o": []}
{"i": [], "o": ["baseline levels of TNF - \u03b1"]}
{"i": ["bilastine"], "o": ["IL - 6 or IL - 8 ."]}
{"i": ["bilastine"], "o": ["IL - 6", "IL - 8"]}
{"i": [], "o": ["severe adverse events", "unexpected serious adverse reactions"]}
{"i": [], "o": []}
{"i": [], "o": ["adverse events"]}
{"i": ["bilastine"], "o": ["sedation", "dizziness"]}
{"i": ["bilastine"], "o": []}
{"i": [], "o": []}
{"i": ["placebo"], "o": ["exanthema", "upper respiratory tract infection", "gastric pain", "constipation", "dyspnoea", "bronchitis / laryngitis"]}
{"i": [], "o": ["adverse responses"]}
{"i": ["bilastine"], "o": []}
{"i": ["bilastine"], "o": []}
{"i": ["bilastine"], "o": ["Sedation"]}
{"i": [], "o": ["Histamine release"]}
{"i": ["bilastine"], "o": ["IL - 6 and IL - 8", "levels of histamine"]}
{"i": [], "o": ["critical temperature thresholds ( CTT )"]}
{"i": ["bilastine"], "o": ["median CTT", "symptom free", "CCU symptoms"]}
{"i": ["bilastine"], "o": []}
{"i": ["bilastine"], "o": ["median CTT", "symptom free ."]}
{"i": ["desloratadine"], "o": ["mean CTT"]}
{"i": [], "o": ["mean CTT"]}
{"i": ["desloratadine"], "o": ["mean CTT"]}
{"i": [], "o": ["symptom free .", "CTT"]}
{"i": ["rupatadine"], "o": ["median CTT"]}
{"i": ["placebo"], "o": ["pruritic response"]}
{"i": ["bilastine"], "o": []}
{"i": [], "o": ["pruritus"]}
{"i": ["bilastine"], "o": []}
{"i": ["bilastine"], "o": ["drowsiness"]}
{"i": ["bilastine", "lorazepam"], "o": []}
{"i": ["bilastine"], "o": ["sedation", "drowsiness"]}
{"i": [], "o": ["concentration of histamine"]}
{"i": ["bilastine"], "o": []}
{"i": ["bilastine"], "o": []}
{"i": ["bilastine"], "o": ["histamine release"]}
{"i": [], "o": ["concentration of histamine"]}
{"i": [], "o": []}
{"i": [], "o": ["IL - 6 and IL - 8"]}
{"i": [], "o": ["IL - 6 .", "IL - 6 and IL - 8", "IL - 8"]}
{"i": [], "o": []}
{"i": ["bilastine"], "o": ["IL - 6 and IL - 8 levels"]}
{"i": ["bilastine"], "o": []}
{"i": [], "o": ["safety", "sedation"]}
